Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Chronic Obstructive Pulmonary Disease Clinical Trials

24 recruiting trials for Chronic Obstructive Pulmonary Disease. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
24
Total Trials
24
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT06974981

Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry

The COPD in LCS Registry will identify and characterize individuals who have functional or radiographic evidence of COPD and are receiving lung cancer screening. Clinical...

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityEnrolling: 4201 location
RECRUITINGPhase 1NCT02966665

: Vascular Function in Health and Disease

Many control mechanisms exist which successfully match the supply of blood with the metabolic demand of various tissues under wide-ranging conditions. One primary regulator of...

Sponsor: Russell RichardsonEnrolling: 4201 location
RECRUITINGNCT07274631

A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine

Chronic inflammatory pulmonary diseases, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis (CF), primary ciliary dyskinesia (PCD) and...

Sponsor: CHU de ReimsEnrolling: 4701 location
RECRUITINGNCT03120481

Controls for Respiratory Diseases

This is the registry of control participants for patients with various respiratory diseases. We screened healthy volunteers who visited Seoul National Hospital Healthcare System...

Sponsor: Seoul National University HospitalEnrolling: 15721 location
RECRUITINGNCT03455686

Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease

This is a single centre exploratory study that aims to apply hyperpolarized xenon-129 (129Xe) magnetic resonance imaging (MRI) methods and measurements in individual patients with...

Sponsor: McMaster UniversityEnrolling: 601 location
RECRUITINGPhase 1NCT05147688

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Pulmonary...

Sponsor: The Foundation for Orthopaedics and Regenerative MedicineEnrolling: 201 location
RECRUITINGNCT06476769

Combined Effects of Blow Bottle Device and Postural Drainage in Moderate to Severe Elderly COPD Patients

It will be a randomized clinical trial. Age of selected subjects will be between 40 to 70 years. Data will be collected from Wazirabad institute of cardiology. There will be 2...

Sponsor: Riphah International UniversityEnrolling: 401 location
RECRUITINGNCT06776601

Digital Therapy in Self-management of COPD Patients

This project adopts a whole-process digital therapy intervention package composed of an inhalation technique assessment device, an electronic inhalant medication monitoring device...

Sponsor: China-Japan Friendship HospitalEnrolling: 6001 location
RECRUITINGNCT06601777

Evaluation of the Effectiveness, Safety, and Cost of a Smart Hospital System for Patients With Chronic Obstructive...

This study aims to analyze the effectiveness/safety/cost of the Smart Homespital system that provides a service that allows patients with Chronic Obstructive Pulmonary Disease to...

Sponsor: Yonsei UniversityEnrolling: 1981 location
RECRUITINGNCT05743582

Innate Immunity in COPD

Chronic Obstructive Pulmonary Disease (COPD) causes obstruction to airflow when breathing out. It is a leading cause of chronic lung disease, hospitalization and death. Smoking is...

Sponsor: University of EdinburghEnrolling: 1892 locations
RECRUITINGPhase 4NCT07053423

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With...

LPS18583 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 4 study with 2 treatment groups. The purpose of this study is to assess the effect...

Sponsor: SanofiEnrolling: 21820 locations
RECRUITINGNCT05785026

Menthol for Dyspnea Relief in Health and COPD

Menthol inhalation (MI) is a novel and promising treatment option for acute relief of dyspnea, however, the underlying ventilatory and/or neural related mechanisms for this relief...

Sponsor: KU LeuvenEnrolling: 1201 location
RECRUITINGPhase 4NCT05772013

Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations

People living with chronic obstructive pulmonary disease (COPD) may experience worsening of symptoms such as shortness of breath, cough and wheezing in addition to changes that...

Sponsor: Dr Ian B WilkinsonEnrolling: 13111 location
RECRUITINGNCT07069829

Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo

Chronic Obstructive Pulmonary Disease is a leading cause of global morbidity and mortality, especially in low- and middle-income countries. Exacerbations accelerate disease...

Sponsor: AstraZenecaEnrolling: 140012 locations
RECRUITINGNCT05306743

PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.

A 3-year cluster randomized controlled trial of the impact of a quality improvement and clinical decision support package versus usual care for patients with modifiable high-risk...

Sponsor: Observational and Pragmatic Research InstituteEnrolling: 1263 locations
RECRUITINGNCT05227547

Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease

To evaluate the regenerative capacities of mesenchymal cells composing the microenvironment of alveolar type 2 cells in a population of patients, undergoing thoracic surgery for...

Sponsor: Centre Hospitalier Intercommunal CreteilEnrolling: 1864 locations
RECRUITINGNCT06432972

Accelerated Pulmonary Rehabilitation in the Preoperative Period

This proposed project will be a single arm, non-masked study. Participants who are actively smoking with a diagnosis of a new lung nodule, either confirmed or suspicious for lung...

Sponsor: University of VermontEnrolling: 201 location
RECRUITINGPhase 1 / Phase 2NCT06603246

A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

This study evaluates the safety, tolerability, and activity of inhaled GDC-6988 in participants with muco-obstructive disease.

Sponsor: Genentech, Inc.Enrolling: 1287 locations
RECRUITINGNCT07384897

Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease

This study aims to better understand the role of immune system cells in lung diseases such as lung cancer, sarcoidosis, and chronic obstructive pulmonary disease (COPD). The...

Sponsor: Université Catholique de LouvainEnrolling: 4251 location
RECRUITINGPhase 1 / Phase 2NCT05746039

Feasibility of Semaglutide in Advanced Lung Disease

The goal of this clinical trial is to learn whether semaglutide, an FDA-approved treatment for diabetes and obesity, is feasible and tolerable in patients with advanced lung...

Sponsor: University of PennsylvaniaEnrolling: 81 location
RECRUITINGNCT05351242

Thermotherapy Against Persistent Bacterial LUNG Infections

The aim of this study is to determine whether an intervention with frequent thermotherapy will be able to reduce the amount of colonizing bacteria in the bronchoalveolar lavage...

Sponsor: Chronic Obstructive Pulmonary Disease Trial Network, DenmarkEnrolling: 1501 location
RECRUITINGNCT06326957

Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention...

Background: Some health conditions make breathing difficult and uncomfortable. When this happens every day, it is called chronic breathlessness. Over 3 million people living with...

Sponsor: King's College Hospital NHS TrustEnrolling: 2461 location
RECRUITINGNCT06046547

Integrating Palliative Care Education in Pulmonary Rehabilitation

Living with chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD) imposes enormous daily challenges, especially at advanced stages, not just to patients...

Sponsor: Aveiro UniversityEnrolling: 581 location
RECRUITINGNCT06068647

Ultrasound and Respiratory Physiological Signals in Lung Diseases

The use of lung ultrasound is instrumental in the evaluation of many chest pathologies and its ability to detect pleuro-pulmonary pathology is widely accepted. However, the use...

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCSEnrolling: 251 location

Frequently Asked Questions

There are currently 24 clinical trials for Chronic Obstructive Pulmonary Disease, with 24 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Chronic Obstructive Pulmonary Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Chronic Obstructive Pulmonary Disease, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.